$5.22 Billion is the total value of C WorldWide Group Holding A/S's 163 reported holdings in Q2 2016. The portfolio turnover from Q1 2016 to Q2 2016 was 30.6% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| HDB | Sell | HDFC BANK LTD | $148,455,000 | +6.7% | 2,237,455 | -0.9% | 2.84% | +5.6% |
| GOOGL | Sell | ALPHABET INCcap stk cl a | $43,880,000 | -12.9% | 62,371 | -5.6% | 0.84% | -13.8% |
| AMGN | Sell | AMGEN INC | $32,307,000 | -9.1% | 212,338 | -10.4% | 0.62% | -9.9% |
| CELG | Sell | CELGENE CORP | $32,098,000 | -6.1% | 325,438 | -4.7% | 0.62% | -7.0% |
| AGN | Sell | ALLERGAN PLC | $27,163,000 | -18.3% | 117,542 | -5.2% | 0.52% | -19.1% |
| CNC | Sell | CENTENE CORP DEL | $19,881,000 | -3.5% | 278,560 | -16.8% | 0.38% | -4.5% |
| BIIB | Sell | BIOGEN INC | $18,656,000 | -14.3% | 77,147 | -7.8% | 0.36% | -15.2% |
| CI | Sell | CIGNA CORPORATION | $13,477,000 | -15.2% | 105,300 | -9.0% | 0.26% | -16.0% |
| TEVA | Sell | TEVA PHARMACEUTICAL INDS LTDadr | $13,311,000 | -21.8% | 265,000 | -16.7% | 0.26% | -22.5% |
| ESRX | Sell | EXPRESS SCRIPTS HLDG CO | $12,757,000 | +1.9% | 168,301 | -7.6% | 0.24% | +0.8% |
| JAZZ | Sell | JAZZ PHARMACEUTICALS PLC | $12,179,000 | -1.5% | 86,189 | -9.0% | 0.23% | -2.5% |
| CEMP | Sell | CEMPRA INC | $12,048,000 | -10.1% | 730,630 | -4.5% | 0.23% | -10.8% |
| TSM | Sell | TAIWAN SEMICONDUCTOR MFG LTDsponsored adr | $8,400,000 | -6.5% | 320,260 | -6.6% | 0.16% | -7.5% |
| MDVN | Sell | MEDIVATION INC | $4,439,000 | +7.7% | 73,622 | -17.9% | 0.08% | +6.2% |
| EGRX | Sell | EAGLE PHARMACEUTICALS INC | $3,778,000 | -53.1% | 97,407 | -51.0% | 0.07% | -53.8% |
| ZLTQ | Sell | ZELTIQ AESTHETICS INC | $3,690,000 | -9.4% | 135,000 | -10.0% | 0.07% | -10.1% |
| ONCE | Sell | SPARK THERAPEUTICS INC | $3,446,000 | +45.2% | 67,400 | -16.2% | 0.07% | +43.5% |
| SUPN | Sell | SUPERNUS PHARMACEUTICALS INC | $2,506,000 | -31.0% | 123,000 | -48.3% | 0.05% | -31.4% |
| LDRH | Sell | LDR HLDG CORP | $2,103,000 | -50.6% | 56,917 | -65.9% | 0.04% | -51.2% |
| AIRM | Sell | AIR METHODS CORP | $1,827,000 | -75.2% | 51,000 | -75.0% | 0.04% | -75.5% |
| MA | Sell | MASTERCARD INCcl a | $1,497,000 | -20.8% | 17,000 | -15.0% | 0.03% | -21.6% |
| IONS | Sell | IONIS PHARMACEUTICALS INC | $815,000 | -63.1% | 35,000 | -35.8% | 0.02% | -62.8% |
| MDT | Sell | MEDTRONIC PLC | $677,000 | -49.3% | 7,800 | -56.2% | 0.01% | -50.0% |
| ASX | Sell | ADVANCED SEMICONDUCTOR ENGRsponsored adr | $141,000 | -36.5% | 25,300 | -33.1% | 0.00% | -25.0% |
| TRXC | Sell | TRANSENTERIX INC | $180,000 | -89.4% | 150,000 | -62.5% | 0.00% | -90.9% |
| ENDP | Exit | ENDO INTL PLC | $0 | – | -17,500 | -100.0% | -0.01% | – |
| DHR | Exit | DANAHER CORP DEL | $0 | – | -8,770 | -100.0% | -0.02% | – |
| DFS | Exit | DISCOVER FINL SVCS | $0 | – | -16,110 | -100.0% | -0.02% | – |
| TGT | Exit | TARGET CORP | $0 | – | -11,200 | -100.0% | -0.02% | – |
| CMCSA | Exit | COMCAST CORP NEWcl a | $0 | – | -17,890 | -100.0% | -0.02% | – |
| SCI | Exit | SERVICE CORP INTL | $0 | – | -57,200 | -100.0% | -0.03% | – |
| TROV | Exit | TROVAGENE INC | $0 | – | -328,584 | -100.0% | -0.03% | – |
| EXAM | Exit | EXAMWORKS GROUP INC | $0 | – | -55,000 | -100.0% | -0.03% | – |
| ACHC | Exit | ACADIA HEALTHCARE PANY IN | $0 | – | -35,000 | -100.0% | -0.04% | – |
| EIX | Exit | EDISON INTL | $0 | – | -26,900 | -100.0% | -0.04% | – |
| TTPH | Exit | TETRAPHASE PHARMACEUTICALS I | $0 | – | -461,510 | -100.0% | -0.04% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2016-07-29
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| VISA INC | 40 | Q2 2024 | 15.5% |
| THERMO FISHER SCIENTIFIC INC | 40 | Q2 2024 | 11.2% |
| HDFC BANK LTD | 40 | Q2 2024 | 3.7% |
| ICICI BK LTD | 40 | Q2 2024 | 2.1% |
| CENTENE CORP DEL | 40 | Q2 2024 | 0.4% |
| DEX INC | 40 | Q2 2024 | 0.6% |
| BIOMARIN PHARMACEUTICAL INC | 40 | Q2 2024 | 0.4% |
| VERTEX PHARMACEUTICALS INC | 40 | Q2 2024 | 0.4% |
| INSULET CORP | 40 | Q2 2024 | 0.5% |
| TAIWAN SEMICONDUCTOR MFG LTD | 39 | Q2 2024 | 1.4% |
View C WorldWide Group Holding A/S's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-07-31 |
| 13F-HR | 2024-05-03 |
| 13F-HR | 2024-02-05 |
| 13F-HR | 2023-11-03 |
| 13F-HR | 2023-08-02 |
| 13F-HR | 2023-05-02 |
| 13F-HR | 2023-02-03 |
| 13F-HR | 2022-11-03 |
| 13F-HR | 2022-08-02 |
| 13F-HR | 2022-05-04 |
View C WorldWide Group Holding A/S's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.